Reason for request

Inclusion on the list of medicines approved for hospital use.


Clinical Benefit


The actual benefit provided by SAVENE in the treatment of anthracycline extravasation is substantial.

Clinical Added Value


In light of the absence of treatment alternatives and despite the methodological inadequacies of the studies contained in the file, the Transparency Committee considers that SAVENE provides a moderate improvement in actual benefit (IAB III) in the treatment of anthracycline extravasations.

Contact Us

Évaluation des médicaments
All our publications